Skip to main content

Procurement Planning NoticeUK Find a Tender Service

Procurement Planning Notice: Unlocking Space for Business: In-orbit R&D and manufacturing of pharmaceuticals RFI

This is a general procurement pre-announcement; it is not an open invitation to tender. Bidding conditions and dates are set in the official notice the buyer publishes later.

Notice details

Buyer
Department for Science, Innovation & Technology
Country
United Kingdom
Published at source
13 August 2026
Notice type
Procurement Planning Notice

Original title

Unlocking Space for Business: In-orbit R&D and manufacturing of pharmaceuticals RFI

Excerpt from the source text

The UK Space Agency is working across government, regulators, industry and healthcare to help create the conditions needed for the in-orbit pharmaceuticals manufacturing and drug discovery market to develop. USB has played a convening role in bringing together the Medicines and Healthcare products Regulatory Agency (MHRA), the Civil Aviation Authority (CAA) and the Regulatory Innovation Office (RIO) within the Department for Business, Innovation, Science and Trade (BIST) to publish a joint statement on regulatory clarity for in-orbit manufacturing of pharmaceuticals. We are also working with MHRA to develop a regulatory roadmap for space-enabled pharmaceutical manufacturing, to provide…

Source and licence

Source: Find a Tender Service (UK) — contains public sector information licensed under the Open Government Licence v3.0; arranged by TenderZoom.

Licence: Open Government Licence v3.0

View official source

This item is prepared automatically from the official source and contains no editorial commentary.